Abstract:Antiangiogenesis therapy has become a hot field in cancer research. Blood vessels of tumor carry specific markers that are usually related to angiogenesis. Study of these heterogeneous molecules in different tumor vessels may be beneficial for promoting antiangiogenic therapy. In this study, we established an in vitro co-culture model of human umbilical vein endothelial cells (HUVECs) and gastric adenocarcinoma cell line SGC7901, screened the peptides binding specifically to the HUVECs co-cultured with gastric cancer cells (Co-HUVECs) using phage display peptides library, and studied the affinity of these peptides to gastric cancer vascular endothelial cells. After four rounds of panning, there was an obvious enrichment for the phages specifically binding to the Co-HUVECs, and the output/input ratio of Co-HUVECs increased about 590-fold (from 0.95×10−7 to 561.25×10−7). Five phage clones (M6, M3, M9, IN12, IN11), which could strongly bind to Co-HUVECs instead of wild-type HUVECs, were characterized by ELISA. In vitro cellular binding assay showed that phage IN11 preferably bound to Co-HUVECs rather than control HUVECs, and the number of the phage IN11 recovered from Co-HUVECs was 5.7- and 16.9-folds, respectively, as much as those from control HUVECs and GES cells. Immunocytochemical and immunohistochemical staining confirmed that phage IN11 could specifically bind to Co-HUVECs as well as vascular endothelial cells in gastric cancer tissue sections. Competitive and inhibitory assay revealed the synthetic peptide GEBP11 (CTKNSYLMC) displayed on phage IN11 could competitively inhibit binding of the phage IN11 to Co-HUVECs. Immunofluorescence microscopy showed that the fluorescence-labeled peptide GEBP11 was located at the membrane and perinuclear cytoplasm of Co-HUVECs. Meanwhile, GEBP11 was found to be able to target the gastric cancer vascular endothelial cells. Therefore, GEBP11 may be a potential candidate for targeted drug delivery in antivascular therapy and diagnosis of gastric cancer.

Ph.D. -C7CTM Phage Display Peptide Library Selection on Gastric Cancer MDR Cells to Yield Specific Binding Peptides

Selection and Characterization of a Peptide Specifically Targeting to Gastric Cancer Cell Line SGC-7901 Using Phage Display

Quantitative Proteomics Analysis of the Role of Tetraspanin-8 in the Drug Resistance of Gastric Cancer.

Characterization of a specific phage-displayed Peptide binding to vasculature of human gastric cancer.

Selection of a Specific Binding Peptide Targeting to Blood Vessel of Human Gastric Cancer in Vivo and Modeling of Its Three Dimensional Structure

Selectively Suppressing Tumor Angiogenesis for Targeted Breast Cancer Therapy by Genetically Engineered Phage.

Screening and Identification of Vascular-Endothelial-cell-specific Binding Peptide in Gastric Cancer

Screening and identification of a CD44v6 specific peptide using improved phage display for gastric cancer targeting

[Mimic Epitope Recognized by Monoclonal Antibody MG7 Against Gastric Cancer Through Screening Phage Displayed Random Peptide Library].

Phage antibody library screening for the selection of novel high-affinity human single-chain variable fragment against gastrin receptor: an in silico and in vitro study

Selection of Lung Cancer-Specific Landscape Phage for Targeted Drug Delivery.

The further characterization of the peptide specifically binding to gastric cancer

Identifying Peptides That Specifically Bind to MDA-MB-468 Breast Cancer Cells*

Tumor-Targeting Peptides Search Strategy for the Delivery of Therapeutic and Diagnostic Molecules to Tumor Cells

Screening and Characterization of Inhibiting Peptides Binding to the Tumor Vascular Growth Factor Receptor

Screening and identification of CD44v9 specific peptide ligand for gastric cancer detection

Screening of a specific peptide binding to esophageal squamous carcinoma cells from phage displayed peptide library.

Selection and identification of a specific peptide binding to ovarian cancer cells from a phage-displayed peptide library

Development and validation of cyclic peptide probe for gastric cancer based on phage display technique

Screening and identification of a specific peptide binding to breast cancer cells from a phage-displayed peptide library

A CD44 specific peptide developed by phage display for targeting gastric cancer